Treace Medical Concepts Inc is a commercial-stage orthopaedic medical device company. It is focused on advancing the standard of care for the surgical management of bunion deformities. The company's patented Lapiplasty 3D Bunion Correction procedure is designed to reproducibly correct all planes of the bunion deformity and address the root cause of the bunion, while allowing patients to return to their active lives quickly. The company operates and manages its business as a single segment: designing, manufacturing, and marketing medical devices for surgeons, ambulatory surgery centers, and hospitals related to the surgical management of bunion and related midfoot deformities.
No direct coverage yet · Showing articles that mention TMCI
Zacks Investment Research
Alphatec (ATEC) Q3 Earnings and Revenues Lag EstimatesAlphatec (ATEC) reported quarterly earnings of $0.09 per share, missing the consensus estimate of $0.11, with revenues also falling short of expectations. The stock has declined 45.6% year-to-date and carries a Zacks Rank #3 (Hold) rating. The Medical-Instruments industry ranks in the bottom 40% of Zacks industries, suggesting broader sector weakness.
Headlines open the publisher's site.
